Pimobendan

Products

Pimobendan is approved for animals in the form of capsules, injectable solution, and chewable tablets. It has been approved in many countries since 1998.

Structure and properties

Pimobendan (C19H18N4O2, Mr = 334.4 g/mol) is a benzimidazole pyridazinone derivative.

Effects

Pimobendan (ATCvet QC01CE90) has vasodilator properties. The effects are due to inhibition of phosphodiesterase type II and type III.

Indications

For the treatment of myocardial insufficiency in dogs.